| Literature DB >> 36176451 |
Yuan Ju1, Haiyue Long2, Ping Zhao1, Ping Xu1, Luwei Sun1, Yongqing Bao1, Pingjing Yu1, Yu Zhang1.
Abstract
Background: Bacterial persisters are thought to be responsible for the recalcitrance and relapse of persistent infections, and they also lead to antibiotic treatment failure in clinics. In recent years, researches on bacterial persisters have attracted worldwide attention and the number of related publications is increasing. The purpose of this study was to better understand research trends on bacterial persisters by identifying and bibliometrics analyzing the top 100 cited publications in this field.Entities:
Keywords: VOSviewer; bacterial persisters; bibliometric analysis; citation analysis; top-cited
Year: 2022 PMID: 36176451 PMCID: PMC9513396 DOI: 10.3389/fphar.2022.1001861
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.988
FIGURE 1The distribution of annual publications and citations.
The top 100 cited studies on bacterial persisters with total citation in WoSCC, Scopus, and Google Scholar databases.
| Total citations | |||||||
|---|---|---|---|---|---|---|---|
| Rank | Title | Journal | Year | WoS | ES | GS | IF |
| 1 | Bacterial persistence as a phenotypic switch | Science | 2004 | 1,815 | 1,883 | 2,986 | 31.853 |
| 2 | Persister cells, dormancy and infectious disease | Nature Reviews Microbiology | 2007 | 1,239 | 1,298 | 2,118 | 14.959 |
| 3 | Persister Cells | Annual Review of Microbiology | 2010 | 1,237 | 1,275 | 2,048 | 12.415 |
| 4 | Persistence of | Nature | 2000 | 1,032 | 1,081 | 1,607 | 25.814 |
| 5 | Platforms for antibiotic discovery | Nature Reviews Drug Discovery | 2013 | 844 | 875 | 1,553 | 37.231 |
| 6 | Mechanisms of antibiotic resistance in bacterial biofilms | International Journal of Medical Microbiology | 2002 | 783 | 840 | 1,450 | 2.403 |
| 7 | Persister cells and tolerance to antimicrobials | FEMS Microbiology Letters | 2004 | 695 | 746 | 1,224 | 1.840 |
| 8 | Biofilms and planktonic cells of | Journal of Bacteriology | 2001 | 618 | 656 | 1,103 | 3.984 |
| 9 | Specialized persister cells and the mechanism of multidrug tolerance in | Journal of Bacteriology | 2004 | 601 | 634 | 1,021 | 4.146 |
| 10 | Distinguishing between resistance, tolerance and persistence to antibiotic treatment | Nature Reviews Microbiology | 2016 | 597 | 615 | 975 | 26.819 |
| 11 | Metabolite-enabled eradication of bacterial persisters by aminoglycosides | Nature | 2011 | 564 | 592 | 815 | 36.280 |
| 12 | Multidrug tolerance of biofilms and persister cells | Current Topics in Microbiology and Immunology | 2008 | 517 | 544 | 940 | 5.102 |
| 13 |
| Frontiers in Cellular and infection Microbiology | 2017 | 508 | 507 | 836 | 3.520 |
| 14 | Biofilm infections, their resilience to therapy and innovative treatment strategies | Journal of Internal Medicine | 2012 | 484 | 503 | 819 | 6.455 |
| 15 | Foamy macrophages and the progression of the human tuberculosis granuloma | Nature Immunology | 2009 | 481 | 504 | 840 | 26.000 |
| 16 | Ciprofloxacin Causes Persister Formation by Inducing the TisB toxin in | Plos Biology | 2010 | 475 | 509 | 725 | 12.472 |
| 17 | Antibiotic tolerance facilitates the evolution of resistance | Science | 2017 | 472 | 483 | 706 | 41.058 |
| 18 | Silver Enhances Antibiotic Activity Against Gram-Negative Bacteria | Science Translational Medicine | 2013 | 458 | 451 | 656 | 14.414 |
| 19 | Recent functional insights into the role of (p)ppGpp in bacterial physiology | Nature Reviews Microbiology | 2015 | 440 | 443 | 669 | 24.727 |
| 20 | Internalization of Salmonella by Macrophages Induces Formation of Nonreplicating Persisters | Science | 2014 | 427 | 448 | 626 | 33.611 |
| 21 | Antibiotic resistance in | Biotechnology Advances | 2019 | 423 | 440 | 722 | 10.744 |
| 22 | Persisters: a distinct physiological state of E-coli | BMC Microbiology | 2006 | 421 | 436 | 698 | 2.896 |
| 23 | Persistent bacterial infections and persister cells | Nature Reviews Microbiology | 2017 | 418 | 428 | 657 | 31.851 |
| 24 | Activated ClpP kills persisters and eradicates a chronic biofilm infection | Nature | 2013 | 416 | 430 | 617 | 42.351 |
| 25 | Molecular Mechanisms Underlying Bacterial Persisters | Cell | 2014 | 399 | 420 | 612 | 32.242 |
| 26 | Toxin-antitoxin systems in bacterial growth arrest and persistence | Nature Chemical Biology | 2016 | 392 | 410 | 574 | 15.066 |
| 27 | Mechanisms of bacterial persistence during stress and antibiotic exposure | Science | 2016 | 386 | 396 | 579 | 37.205 |
| 28 | Bacterial persistence: A model of survival in changing environments | Genetics | 2005 | 384 | 392 | 650 | 4.289 |
| 29 | The challenge of treating biofilm-associated bacterial infection | Clinical Pharmacology & therapeutics | 2007 | 381 | 406 | 656 | 8.033 |
| 30 | Growth Rate-Dependent Global Effects on Gene Expression in Bacteria | Cell | 2009 | 375 | 400 | 663 | 31.152 |
| 31 | Bacterial persistence by RNA endonucleases | Proceedings of the National Academy of Sciences of the United States of America | 2011 | 373 | 397 | 553 | 9.681 |
| 32 | Microbial cell individuality and the underlying sources of heterogeneity | Nature Reviews Microbiology | 2006 | 367 | 385 | 576 | 15.845 |
| 33 | Emergence of | Journal of Bacteriology | 2010 | 361 | 381 | 577 | 3.726 |
| 34 | Dynamic Persistence of Antibiotic-Stressed Mycobacteria | Science | 2013 | 342 | 364 | 515 | 31.477 |
| 35 | Bacterial Toxin-Antitoxin Systems: More Than Selfish Entities? | Plos Genetics | 2009 | 339 | 374 | 654 | 9.532 |
| 36 | Bacterial Persister Cell Formation and Dormancy | Applied and Environmental Microbiology | 2013 | 334 | 343 | 568 | 3.952 |
| 37 | Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy | Proceedings of the National Academy of Sciences of the United States of America | 2009 | 324 | 347 | 542 | 9.432 |
| 38 | Definitions and guidelines for research on antibiotic persistence | Nature Reviews Microbiology | 2019 | 324 | 339 | 514 | 34.209 |
| 39 | Growth of | Molecular Microbiology | 2008 | 317 | 347 | 512 | 5.213 |
| 40 | Persister cells and the riddle of biofilm survival | Biochemistry-Moscow | 2005 | 311 | 316 | 650 | 0.858 |
| 41 | Persister formation in | Nature Microbiology | 2016 | 303 | 310 | 417 | N/A |
| 42 | Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum | Plos Medicine | 2008 | 294 | 229 | 442 | 12.185 |
| 43 | SOS Response Induces Persistence to Fluoroquinolones in | Plos Genetics | 2009 | 293 | 313 | 494 | 9.532 |
| 44 | Toxins, Targets, and Triggers: An Overview of Toxin-Antitoxin Biology | Molecular Cell | 2018 | 292 | 301 | 419 | 14.548 |
| 45 | Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations | Nature | 2014 | 284 | 296 | 448 | 41.456 |
| 46 | Toxin-Antitoxin Systems Influence Biofilm and Persister Cell Formation and the General Stress Response | Applied and Environmental Microbiology | 2011 | 284 | 300 | 435 | 3.829 |
| 47 | Signaling-mediated bacterial persister formation | Nature Chemical Biology | 2012 | 278 | 294 | 417 | 12.948 |
| 48 | A Novel | Plos One | 2009 | 277 | 294 | 423 | 4.351 |
| 49 | Characterization of the hipA7 allele of | Molecular Microbiology | 2003 | 268 | 274 | 423 | 5.563 |
| 50 | Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies | Journal of Medical Microbiology | 2011 | 268 | 274 | 432 | 2.502 |
| 51 | Emergence of vancomycin tolerance in Streptococcus pneumoniae | Nature | 1999 | 267 | 306 | 461 | 29.491 |
| 52 | Structure-Activity Relationships for a Series of Quinoline-Based Compounds Active against Replicating and Nonreplicating | Journal of Medicinal Chemistry | 2009 | 265 | 265 | 324 | 4.802 |
| 53 | Microbial Persistence and the Road to Drug Resistance | Cell Host and Microbe | 2013 | 261 | 285 | 445 | 12.194 |
| 54 | Characterization and Transcriptome Analysis of | Mbio | 2011 | 238 | 254 | 341 | 5.311 |
| 55 | Regulation of phenotypic variability by a threshold-based mechanism underlies bacterial persistence | Proceedings of the National Academy of Sciences of the United States of America | 2010 | 238 | 244 | 365 | 9.771 |
| 56 | Molecular Mechanisms of HipA-Mediated Multidrug Tolerance and Its Neutralization by HipB | Science | 2009 | 236 | 251 | 370 | 29.747 |
| 57 | New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects | Lancet infectious Diseases | 2014 | 233 | 254 | 378 | 22.433 |
| 58 | Metabolic Control of Persister Formation in | Molecular Cell | 2013 | 224 | 235 | 339 | 14.464 |
| 59 | ATP-Dependent Persister Formation in | Mbio | 2017 | 220 | 224 | 287 | 6.689 |
| 60 | Microbial phenotypic heterogeneity and antibiotic tolerance | Current Opinion in Microbiology | 2007 | 216 | 231 | 385 | 7.654 |
| 61 | Toxin-antitoxin systems: why so many, what for? | Current Opinion in Microbiology | 2010 | 213 | 223 | 336 | 7.714 |
| 62 | Toxin-antitoxin modules as bacterial metabolic stress managers | Trends in Biochemical Sciences | 2005 | 211 | 215 | 297 | 13.343 |
| 63 | The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms | Science Translational Medicine | 2018 | 207 | 208 | 241 | 17.200 |
| 64 | Role of global regulators and nucleotide metabolism in antibiotic tolerance in | Antimicrobial Agents and Chemotherapy | 2008 | 204 | 214 | 337 | 4.716 |
| 65 | Enhanced Efflux Activity Facilitates Drug Tolerance in Dormant Bacterial Cells | Molecular Cell | 2016 | 202 | 205 | 303 | 14.714 |
| 66 | A new type V toxin-antitoxin system where mRNA for toxin GhoT is cleaved by antitoxin GhoS | Nature Chemical Biology | 2012 | 199 | 212 | 318 | 12.948 |
| 67 | Arrested Protein Synthesis Increases Persister-Like Cell Formation | Antimicrobial Agents and Chemotherapy | 2013 | 198 | 203 | 276 | 4.451 |
| 68 | A new class of synthetic retinoid antibiotics effective against bacterial persisters | Nature | 2018 | 191 | 196 | 238 | 43.070 |
| 69 | Biofilms in periprosthetic orthopedic infections | Future Microbiology | 2014 | 187 | 187 | 294 | 4.275 |
| 70 | Persistent bacterial infections, antibiotic tolerance, and the oxidative stress response | Virulence | 2013 | 182 | 185 | 309 | 3.319 |
| 71 | Phenotypic Variation of Salmonella in Host Tissues Delays Eradication by Antimicrobial Chemotherapy | Cell | 2014 | 181 | 191 | 251 | 32.242 |
| 72 | Toxins Hha and CspD and small RNA regulator Hfq are involved in persister cell formation through MqsR in | Biochemical and Biophysical Research Communications | 2010 | 168 | 174 | 253 | 2.595 |
| 73 | A problem of persistence: still more questions than answers? | Nature Reviews Microbiology | 2013 | 168 | 177 | 266 | 23.317 |
| 74 | Identification of Anti-virulence Compounds That Disrupt Quorum-Sensing Regulated Acute and Persistent Pathogenicity | Plos Pathogens | 2014 | 167 | 175 | 236 | 7.562 |
| 75 | Eradication of bacterial persisters with antibiotic-generated hydroxyl radicals | Proceedings of the National Academy of Sciences of the United States of America | 2012 | 166 | 177 | 247 | 9.737 |
| 76 | Sterilizing activities of fluoroquinolones against rifampin-tolerant populations of | Antimicrobial Agents and Chemotherapy | 2003 | 165 | 190 | 300 | 4.246 |
| 77 | Role of Oxidative Stress in Persister Tolerance | Antimicrobial Agents and Chemotherapy | 2012 | 164 | 179 | 254 | 4.565 |
| 78 | Increased persistence in | Journal of Bacteriology | 2006 | 163 | 172 | 261 | 3.993 |
| 79 | Formation, physiology, ecology, evolution and clinical importance of bacterial persisters | FEMS Microbiology Reviews | 2017 | 163 | 168 | 254 | 11.392 |
| 80 | Targeting Persisters for Tuberculosis Control | Antimicrobial Agents and Chemotherapy | 2012 | 163 | 163 | 270 | 4.565 |
| 81 | Ectopic overexpression of wild-type and mutant hipA genes in | Journal of Bacteriology | 2006 | 162 | 166 | 263 | 3.993 |
| 82 | Role of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated | Journal of Medical Microbiology | 2009 | 160 | 174 | 280 | 2.272 |
| 83 | Phenotypic bistability in | Molecular Systems Biology | 2014 | 158 | 164 | 248 | 10.872 |
| 84 | Starvation, Together with the SOS Response, Mediates High Biofilm-Specific Tolerance to the Fluoroquinolone Ofloxacin | Plos Genetics | 2013 | 157 | 170 | 262 | 8.167 |
| 85 | Multiple Toxin-Antitoxin Systems in | Toxins | 2014 | 157 | 155 | 216 | 2.938 |
| 86 | HipA-mediated antibiotic persistence via phosphorylation of the glutamyl-tRNA-synthetase | Nature Communications | 2013 | 156 | 166 | 229 | 10.742 |
| 87 |
| Journal of Bacteriology | 2010 | 155 | 176 | 272 | 3.726 |
| 88 | Evaluation of short synthetic antimicrobial peptides for treatment of drug-resistant and intracellular | Scientific Reports | 2016 | 154 | 158 | 192 | 4.259 |
| 89 | Isocitrate lyase mediates broad antibiotic tolerance in | Nature Communications | 2014 | 154 | 168 | 217 | 11.470 |
| 90 | PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in | Antimicrobial Agents and Chemotherapy | 2007 | 154 | 157 | 244 | 4.390 |
| 91 | Persistence of | Plos One | 2012 | 153 | 156 | 242 | 3.730 |
| 92 | Persister cells, the biofilm matrix and tolerance to metal cations in biofilm and planktonic | Environmental Microbiology | 2005 | 153 | 162 | 246 | 4.559 |
| 93 | Dormancy Is Not Necessary or Sufficient for Bacterial Persistence | Antimicrobial Agents and Chemotherapy | 2013 | 151 | 155 | 230 | 4.451 |
| 94 | Bridging the gap between viable but non-culturable and antibiotic persistent bacteria | Trends in Microbiology | 2015 | 151 | 167 | 238 | 9.500 |
| 95 | Biofilm-related disease | Expert Review of Anti-infective therapy | 2018 | 149 | 155 | 228 | 3.090 |
| 96 | Letting Sleeping dos Lie: Does Dormancy Play a Role in Tuberculosis? | Annual Review of Microbiology, Vol 64, 2010 | 2010 | 149 | 162 | 265 | N/A |
| 97 | Carbon Sources Tune Antibiotic Susceptibility in | Cell Chemical Biology | 2017 | 148 | 156 | 201 | 5.592 |
| 98 | Bacterial persistence and expression of disease | Clinical Microbiology Reviews | 1997 | 148 | 146 | 275 | 8.585 |
| 99 | GlpD and PlsB participate in persister cell formation in Eschetichia coli | Journal of Bacteriology | 2006 | 147 | 145 | 237 | 3.993 |
| 100 | Kinase activity of overexpressed HipA is required for growth arrest and multidrug tolerance in | Journal of Bacteriology | 2006 | 147 | 153 | 217 | 3.993 |
WoS represented WoSCC database;
ES represented Elsevier Scopus database.
SC represented Google Scholar database.
IF showed the IF of journal in the year of publication, and the N/A represented that the journal IF had not been assigned in the year of publication.
FIGURE 2The relationship among total citations, mean citations per year, and publication age in WoSCC database. (A) Association of total citations with publication year (r = −0.488, p < 0.001 =; (B) Association of mean citations per year with publication age (p = 0.248).
Journals of the top 100 cited publications on bacterial persisters.
| Journal | Number of publications | Total citations | Average citation count per paper | 2021 IF |
|---|---|---|---|---|
| Journal of Bacteriology | 8 | 2,354 | 294 | 3.476 |
| Nature Reviews Microbiology | 7 | 3,553 | 508 | 78.297 |
| Antimicrobial Agents and Chemotherapy | 7 | 1,199 | 171 | 5.938 |
| Nature | 6 | 2,754 | 459 | 69.504 |
| Science | 6 | 3,678 | 613 | 63.798 |
| Proceedings of the National Academy of Sciences | 4 | 1,101 | 275 | 12.779 |
| Cell | 3 | 955 | 318 | 66.85 |
| Molecular Cell | 3 | 718 | 239 | 19.328 |
| Nature Chemical Biology | 3 | 869 | 289 | 16.29 |
| Plos Genetics | 3 | 789 | 263 | 6.02 |
| Science Translational Medicine | 2 | 665 | 332 | 19.359 |
| Nature Communications | 2 | 310 | 155 | 17.694 |
| Annual Review of Microbiology | 2 | 1,386 | 693 | 16.232 |
| Mbio | 2 | 458 | 229 | 7.786 |
| Current Opinion in Microbiology | 2 | 429 | 214 | 7.584 |
| Applied and Environmental Microbiology | 2 | 618 | 309 | 5.005 |
| Molecular Microbiology | 2 | 585 | 292 | 3.979 |
| Plos One | 2 | 430 | 215 | 3.752 |
| Journal of Medical Microbiology | 2 | 428 | 214 | 3.196 |
| Nature Reviews Drug Discovery | 1 | 844 | 844 | 112.288 |
| Lancet infectious Diseases | 1 | 233 | 233 | 71.421 |
| Clinical Microbiology Reviews | 1 | 148 | 148 | 50.129 |
| Cell Host and Microbe | 1 | 261 | 261 | 31.316 |
| Nature Immunology | 1 | 481 | 481 | 31.25 |
| Nature Microbiology | 1 | 303 | 303 | 30.964 |
| Trends in Microbiology | 1 | 151 | 151 | 18.23 |
| Biotechnology Advances | 1 | 423 | 423 | 17.681 |
| FEMS Microbiology Reviews | 1 | 163 | 163 | 15.177 |
| Trends in Biochemical Sciences | 1 | 211 | 211 | 14.264 |
| Journal of Internal Medicine | 1 | 484 | 484 | 13.068 |
| Molecular Systems Biology | 1 | 158 | 158 | 13.068 |
| Plos Medicine | 1 | 294 | 294 | 11.613 |
| Plos Biology | 1 | 475 | 475 | 9.593 |
| Cell Chemical Biology | 1 | 148 | 148 | 9.039 |
| Journal of Medicinal Chemistry | 1 | 265 | 265 | 8.039 |
| Plos Pathogens | 1 | 167 | 167 | 7.464 |
| Clinical Pharmacology & therapeutics | 1 | 381 | 381 | 6.903 |
| Frontiers in Cellular and infection Microbiology | 1 | 508 | 508 | 6.073 |
| Expert Review of Anti-infective therapy | 1 | 149 | 149 | 5.854 |
| Environmental Microbiology | 1 | 153 | 153 | 5.476 |
| Virulence | 1 | 182 | 182 | 5.428 |
| Toxins | 1 | 157 | 157 | 5.075 |
| Scientific Reports | 1 | 154 | 154 | 4.996 |
| Current Topics in Microbiology and Immunology | 1 | 517 | 517 | 4.737 |
| BMC Microbiology | 1 | 421 | 421 | 4.465 |
| Genetics | 1 | 384 | 384 | 4.402 |
| International Journal of Medical Microbiology | 1 | 783 | 783 | 3.658 |
| Future Microbiology | 1 | 187 | 187 | 3.553 |
| Biochemical and Biophysical Research Communications | 1 | 168 | 168 | 3.322 |
| Biochemistry-Moscow | 1 | 311 | 311 | 2.824 |
| FEMS Microbiology Letters | 1 | 695 | 695 | 2.82 |
Countries of the top 100 cited publications on bacterial persisters.
| Country | Number of publications | Total citations | Average citation count |
|---|---|---|---|
| United States | 64 | 23,130 | 361 |
| England | 8 | 2,676 | 334 |
| Israel | 7 | 2,239 | 320 |
| Belgium | 5 | 1,194 | 239 |
| Switzerland | 3 | 681 | 227 |
| Sweden | 2 | 924 | 462 |
| Denmark | 2 | 678 | 339 |
| Canada | 2 | 576 | 288 |
| France | 2 | 314 | 157 |
| New Zealand | 1 | 508 | 508 |
| Netherlands | 1 | 207 | 207 |
| China | 1 | 202 | 202 |
| India | 1 | 160 | 160 |
| Spain | 1 | 149 | 149 |
The country distributions were extracted based on the country of first author.
Institutions with more than two papers in the top 100 cited publications on bacterial persisters.
| Institution | Country | Number of publications | Total citations | Average citation count |
|---|---|---|---|---|
| Northeastern University | United States | 20 | 9,451 | 472 |
| The Hebrew University of Jerusalem | Israel | 7 | 2,239 | 320 |
| Boston University | United States | 5 | 1,885 | 377 |
| The Rockefeller University | United States | 3 | 2,415 | 805 |
| Harvard University | United States | 3 | 464 | 155 |
| University of North Dakota | United States | 2 | 430 | 215 |
| University of Illinois | United States | 2 | 428 | 214 |
| Tulane University | United States | 2 | 301 | 150 |
| Texas A&M University | United States | 2 | 452 | 226 |
| Princeton University | United States | 2 | 375 | 188 |
| Pennsylvania State University | United States | 2 | 532 | 266 |
| Newcastle University | England | 2 | 772 | 386 |
| Johns Hopkins University | United States | 2 | 317 | 158 |
| Brown University | United States | 2 | 583 | 292 |
| Broad Institute of MIT & Harvard | United States | 2 | 348 | 174 |
The institution distributions were extracted based on the institution of first author.
Authors with more than two first-author or last-author publications in the top 100 cited publications on bacterial persisters.
| First author | Last author | ||||
|---|---|---|---|---|---|
| Author | Institution | Number of papers | Author | Institution | Number of papers |
| Kim Lewis | Northeastern University | 5 | Kim Lewis | Northeastern University | 13 |
| Nathalie Q. Balaban | The Rockefeller University | 3 | James J. Collins | Boston University | 6 |
| Iris Keren | Northeastern University | 3 | Kenn Gerdes | University of Copenhagen | 5 |
| Brian P. Conlon | Northeastern University | 2 | Nathalie Q. Balaban | The Hebrew University of Jerusalem | 4 |
| Jose Luis Del Pozo | Clinical University of Navarra | 2 | Thomas K. Wood | Texas A&M University | 4 |
| Tobias Dörr | Northeastern University | 2 | John D. McKinney | The Hebrew University of Jerusalem | 3 |
| Sarah Schmidt Grant | Broad Institude of MIT & Harvard | 2 | Michael R. Barer | University of London | 2 |
| Alexander Harms | University of Copenhagen | 2 | Mark P. Brynildsen | Princeton University | 2 |
| Shaleen B. Korch | University of North Dakota | 2 | Thomas M. Hill | University of North Dakota | 2 |
| Etienne Maisonneuve | Newcastle University | 2 | Deborah T. Hung | Broad Institude MIT & Harvard | 2 |
| Amy L. Spoering | Northeastern University | 2 | Stanislas Leibler | The Rockefeller University | 2 |
| Laurence Van Melderena | University of Libre Bruxelles | 2 | Jan Michiels | Katholieke University Leuven | 2 |
| Xiaoxue Wang | Brown University | 2 | Marin Vulić | Northeastern University | 2 |
FIGURE 3Co-occurrence network of keywords identified from top 100 cited publications on bacterial persisters. The red cluster was about the in vitro and in vivo studies on Mycobacterium tuberculosis. Researches on E. coli (blue cluster), P. aeruginosa (green cluster), and S. aureus (yellow cluster) have also been extensively studied. The yellow cluster was also focused on the role of persisters in biofilm. The purple cluster and the light blue cluster were about the mechanism of persisters formation.